Ga. Ascoli et al., LIGAND-BINDING TO A HUMAN SERUM-ALBUMIN STATIONARY-PHASE - USE OF SAME-DRUG COMPETITION TO DISCRIMINATE PHARMACOLOGICALLY RELEVANT INTERACTIONS, BMC. Biomedical chromatography, 12(5), 1998, pp. 248-254
Citations number
34
Categorie Soggetti
Chemistry Analytical","Biochemical Research Methods",Biology,"Pharmacology & Pharmacy
A technique based on a human serum albumin (HSA) stationary phase high
-pressure liquid chromatography (HPLC) has been successfully used for
the past few years to characterize the interactions between HSA and ne
w substrates. Immobilized HSA conserves the binding properties of the
protein in solution, allowing fast and reliable analyses of binding in
teractions. Nevertheless, clear evidence that all binding mechanisms o
f HSA-HPLC are pharmacologically relevant is so far lacking. In partic
ular, nonstoichiometric interactions of injected ligands with stationa
ry phase components such as silica and the amino acid medium (other th
an protein binding areas) might interfere with the correlation between
chromatographic retention and HSA binding. Here we present a quantita
tive method to distinguish between the molecular interactions of a lig
and with binding areas of potential pharmacological interest and other
, non-saturable binding mechanisms. Such a method, based on HPLC same
ligand displacement, is simple and reliable, as confirmed by in situ p
rotein denaturation. Consequently, we were able to distinguish between
different types of competitions detected in the co-binding of two dru
gs to HSA. (C) 1998 John Wiley & Sons, Ltd.